Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026)

Viking Therapeutics (VKTX) has 13 years of Non-Current Assets data on file, last reported at $33000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 96.6% year-over-year to $33000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 61.39% YoY), and the FY2025 full-year result was $131000.0, down 88.14% from the prior year.
• Non-Current Assets slipped to $33000.0 in Q1 2026, from $131000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.7 million in Q1 2022 to a low of $33000.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 1011.19% in 2022 and sank 96.6% in 2026, its largest moves.
• Tracing VKTX's Non-Current Assets over 5 years: stood at $1.5 million in 2022, then retreated by 15.04% to $1.3 million in 2023, then decreased by 12.65% to $1.1 million in 2024, then sank by 88.14% to $131000.0 in 2025, then plunged by 74.81% to $33000.0 in 2026.
• Business Quant data shows VKTX's Non-Current Assets at $33000.0 in Q1 2026, $131000.0 in Q4 2025, and $712000.0 in Q3 2025.